###begin article-title 0
###xml 113 116 113 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 224 227 224 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 235 238 235 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 420 423 420 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
During growth of the embryonic eye, dose- and site-specific expression of heparin-binding growth factors is critical for the formation of an appropriate vascular supply. Overexpression of vascular endothelial growth factor-A188 (VEGF-A188), a strongly heparin-binding, endothelial-specific mitogen, leads to severe disturbance of vascular and overall ocular morphology. This study aimed to evaluate the effects of VEGF-A188 overexpression on growth of ocular tissue components.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 146 149 146 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 150 165 <span type="species:ncbi:10090">transgenic mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
Stereological and immunohistochemical methods were employed to identify the vascular profiles, ocular tissue proportions, and cell types in VEGF-A188 transgenic mice and compare them with wild-type mice.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 9 12 9 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 13 28 <span type="species:ncbi:10090">transgenic mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 304 319 <span type="species:ncbi:10090">transgenic mice</span>
In VEGF-A188 transgenic mice, both lens tissue and total ocular volume were reduced, whereas cross-sectional areas of hyaloid blood vessels, retina, iris, and optic stalk tissues were significantly increased compared to wild-type mice. Endothelial and pericyte cell numbers in the hyaloid vasculature of transgenic mice were increased three fold, with pericytes assuming their characteristic extraluminal position.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 35 41 <span type="species:ncbi:10090">murine</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 236 242 <span type="species:ncbi:10090">murine</span>
Overexpression of VEGF-A188 in the murine lens results in microphthalmia, in addition to hypertrophy and persistence of the hyaloid vasculature. This is similar to the human disorder persistent hyperplastic primary vitreous (PHPV). The murine model is a useful, experimental paradigm for investigation of this condition.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 804 805 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 806 807 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 999 1000 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1001 1002 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
The concentration and distribution of matrix-bound growth factors is critical during cellular differentiation and for appropriate tissue patterning in embryogenesis [1]. For instance, in the developing eye, retinal differentiation and growth is dependent on signals emanating in a temporally restricted pattern from the primitive lens. Ocular morphology is, therefore, intimately associated with the rapid expansion of the lens, which throughout embryogenesis, is supported by a tightly adherent circulation system termed the hyaloid vasculature (HV) [1]. During this rapid phase of growth, the lens produces a variety of peptide growth factors that serve to support localized tissue expansion and the temporally restricted maintenance of the HV [1]. Among these factors are FGF2, PDGF-beta, and VEGF-A [1-3]. In the case of the vascular endothelium, VEGF-A levels and the cellular expression pattern is normally tightly regulated, with modest alterations, resulting in embryonic lethal phenotypes [4-7]. These studies reinforce the critical nature of VEGF-A expression in the development and maintenance of the vascular system. However, tissue-restricted expression of VEGF-A and its major isoforms in the eye, due to the nonlethal nature of resultant phenotypes, allows a fuller appreciation of the consequences of misexpression of isoforms of this critical growth factor, particularly in the pathogenesis of ocular diseases.
###end p 11
###begin p 12
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 191 194 191 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 337 340 337 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 501 504 501 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">120</sub>
###xml 515 518 515 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">164</sub>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 851 854 851 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 898 901 898 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 14 20 <span type="species:ncbi:10090">murine</span>
During normal murine HV development, VEGF-A is principally secreted by lens epithelial cells located at the lens equator, and transcripts of the gene are downregulated perinatally [8]. VEGF-A188, one specific isoform of VEGF-A, is transcribed from all eight exons of the gene and strongly binds heparin-associated residues [9-11]. VEGF-A188 is immediately matrix-bound following secretion [12] and is most highly expressed in the lung [13]. During embryonic development, the soluble isoforms of VEGF-A120 and VEGF-A164 are the major isoforms expressed [13] with lens capsule heparin-sulphate proteoglycans (HSPG) potentially acting as a VEGF-A reservoir [14]. A number of ocular pathologies are characterized by deregulated neovascularization, and these conditions correlate with increased levels of total VEGF-A [15-17] - most specifically the VEGF-A165 isoform [1,18]. However, the role of VEGF-A188, the most tightly bound VEGF-A isoform, during development and in the pathophysiology of ocular disease remains to be determined.
###end p 12
###begin p 13
###xml 132 135 132 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
In this study, we analyze and interpret an ocular phenotype in transgenic mice resulting from lens-specific overexpression of VEGF-A188. The evidence from this study supports the hypothesis that the microphthalmia and lens anomalies are a direct result of perturbations in the vascular morphology of the HV, while the retinal hypertrophy may be a direct consequence of the retinal ganglion cell responses to this growth factor. These results have particular relevance for human fetal conditions characterized by ocular vascular abnormalities, such as retinopathy of prematurity (ROP) and persistent hyperplastic primary vitreous (PHPV), establishing the experimental paradigm that vascular malformation can result in the gross ocular pathologies characteristic of these conditions.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Animal model
###end title 15
###begin p 16
###xml 62 65 62 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">120</sub>
###xml 73 76 73 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">164</sub>
###xml 88 91 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 180 183 180 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 388 391 388 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 532 535 524 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1491 1539 1482 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Guide for the Care and Use of Laboratory Animals</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 167 173 <span type="species:ncbi:10090">murine</span>
###xml 235 250 <span type="species:ncbi:10090">transgenic mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
The transgene construction, genotyping, and analysis of VEGF-A120, VEGF-A164, and VEGF-A188 mice is described elsewhere [19]. In brief, the open reading frame cDNA of murine VEGF-A188 was cloned in frame into a CPV2 construct [1], and transgenic mice were derived according to standard methodologies. The mice generated by these methods demonstrated lens-specific expression of the VEGF-A188 protein from the alphaA-crystallin promoter. In our study, adult female C57Bl6J mice (8 weeks old) and heterozygous alphaA-crystallin-VEGF-A188 transgenic males were housed in a 12 h:12 h light-dark schedule and were allowed to mate. T females were examined and the presence of a vaginal plug was defined as embryonic day 0.5 (E0.5; n=19 pregnant dams). The females were euthanized and their gravid uteri were carefully dissected free. After amnionectomy, the fetuses were delivered, euthanized, and eyes were enucleated. One eye from each embryo was fixed in 10% buffered formal saline (BFS; pH 7.4) overnight, subsequently embedded in araldite, and sectioned for stereological analysis. The contralateral eye was fixed in 4% paraformaldehyde for 30 min, embedded in paraffin, sectioned (5 mum) and prepared for either immunohistochemical or TUNEL staining or fixed in 2.5% glutaraldehyde in cacodylate buffer for ultrastructural studies. All experiments adhered to Home Office (National) and institutional guidelines (comparable to those published by the Institute for Laboratory Animal Research, Guide for the Care and Use of Laboratory Animals).
###end p 16
###begin title 17
Ocular stereology
###end title 17
###begin p 18
###xml 569 571 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 572 574 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
A total of five wild-type mice and six transgenic littermates were randomly selected from the total population of collected fetuses. Following fixation, eyes were processed, critically orientated in a mold, and embedded in araldite. Serial sections (0.5 mum thick) were cut at 50 mum intervals through the eye, sections placed onto slides and subsequently stained with 2% toluidine blue. A three-stage stereological analysis was performed to determine (1) ocular volume, (2) tissue and vascular fractions, and (3) vascular morphometry using systematic random sampling [20,21]. Light microscopic images were obtained using an Olympus microscope and electronic images were captured with the aid of an Olympus T4040 digital camera. Each section was visualized and stereological analysis performed with the aid of the "QProdit" computer imaging software (Leica Imaging Systems, Cambridge, UK).
###end p 18
###begin title 19
Ocular volume
###end title 19
###begin p 20
The perimeter of each eye section was traced and the area calculated. Cross-sectional areas from individual sections were multiplied by 50 (to take into account that sections were cut at 50 mum intervals) and subsequently summed to determine fetal ocular volume.
###end p 20
###begin title 21
Tissue fraction
###end title 21
###begin p 22
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Two systematically random views [21] of each eye section were collected, stored, and analyzed with the aid of a 96-point grid layout. The ocular tissues were assigned to one of 11 tissue-type groups based on their location and histological phenotype: retina, lens stroma, cornea, vitreous humor, aqueous humor, iris, lens hemorrhage, lenticular hyaloid vasculature, retinal hyaloid vasculature, optic stalk, and nonocular tissue (includes the sclera and eyelid).
###end p 22
###begin title 23
Vascular morphometry
###end title 23
###begin p 24
A photomicrograph of each section containing HV was analyzed by tracing around each blood vessel. Vessels within the "broken lines" were included within the count, whereas vessels crossing the solid lines were excluded. Blood vessel lengths, cross-sectional areas, diameters, and volumes were calculated using the tissue fraction and ocular volume data based on the following formulas:
###end p 24
###begin title 25
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Measurement of corneal thickness in neonatal mice
###end title 25
###begin p 26
###xml 755 758 754 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 886 891 <span type="species:ncbi:10090">mouse</span>
Heterozygous male transgenic mice were crossed with wild-type female mice, and the eyes from resulting litters (P2) were enucleated, fixed in formalin overnight, and embedded in araldite. Sections were cut (5 mum thick) through the geometric center of the eye (containing the optic nerve; located using light-microscopy), placed onto microscope slides, and stained with hematoxylin and eosin. The phenotype of each pup was identified from its ocular morphology as either transgenic or wild-type. The number of cell layers in the cornea was counted manually under a final magnification of 200X. A nonparametric Friedman test was utilized to ensure that there were no significant differences between wild-type embryos selected from litters containing VEGF-A188 mice, and one-way analysis of variance (ANOVA) with post-hoc testing (SPSS v11.0) was used to compare wild-type and transgenic mouse corneas.
###end p 26
###begin title 27
Transmission electron microscopy
###end title 27
###begin p 28
Ocular samples were embedded in Epon Araldite (TAAB, Aldermaston, Berks, UK), and semithin sections (about 0.8 mum thickness) were cut from blocks on a Reichert-Jung Ultracut-E microtome (Leica Microsystems, Nussloch, Germany), stained with 2% toluidine blue, and examined prior to further ultrastructural analysis. Ultrathin sections of gold interference color (about 80 nm thickness) were cut, and contrasted with uranyl acetate and lead citrate. Sections were viewed using a JEOL JEM-1010 transmission electron microscope (JEOL, Tokyo, Japan) at an accelerating voltage of 80 kV. Electronic images were captured on a Kodak Megaplus camera model 1.6i (Kodak, San Diego, CA).
###end p 28
###begin title 29
Scanning Electron Microscopy
###end title 29
###begin p 30
Specimens were fixed in Karnovsky's fixative solution (2% paraformaldehyde/2% glutaraldehyde in 0.1 M phosphate buffer; pH 7.4) for 1 h, washed several times with PBS for 15 min each, followed by post fixation with 1% osmium tetroxide in 0.1 M phosphate buffer for 1 h. After rinsing with PBS for a minimum of 15 min, the specimens were dehydrated with a series of graded ethyl alcohols (70% for 15 min, 95% for 15 min. and three changes of 100% for 10 min each). The samples were then dried using hexamethyldisilazane (HMDS; Sigma-Aldrich, UK). After drying, the specimens were mounted on aluminium stubs with adhesive tabs and coated with gold for 3 min using a Polaron (Energy Beam Sciences, Agawam, MA) sputter coater. The specimens were examined on an AMRAY 1000A (Bedford, MA) scanning electron microscope.
###end p 30
###begin title 31
Immunohistochemistry
###end title 31
###begin p 32
Immunohistochemical detection of VEGF-A (1:100 dilution in PBS; Santa Cruz Biotechnology, Inc, Santa Cruz, CA), heparan sulfate proteoglycan (HSPG, 1:100 dilution in PBS; Upstate Biotechnology, Charlottesville, VA), macrophage cell surface marker F4/80 (1:150 dilution in PBS; Southern Biotechnology, Birmingham, AL) or alpha-smooth muscle actin antibodies (1:400 dilution in PBS; Sigma) was carried out according to the manufacturer's instructions using the Vectastain (Burlingame, CA), ABC staining method.
###end p 32
###begin title 33
Statistical Analysis
###end title 33
###begin p 34
Statistical comparisons between groups were assessed using a one-way ANOVA with post-hoc testing, with a p<0.05 considered as significant.
###end p 34
###begin title 35
Results
###end title 35
###begin p 36
###xml 45 48 45 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 113 124 113 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,B</xref>
###xml 368 379 368 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B,D</xref>
###xml 480 489 480 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1D</xref>
###xml 772 783 772 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1E-H</xref>
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
###xml 206 221 <span type="species:ncbi:10090">transgenic mice</span>
The gross anatomical features in adult VEGF-A188 transgenic mice include microphthalmia and bilateral cataracts (Figure 1A,B; insets). The characteristic feature of sections from eyes of late fetal (E18.5) transgenic mice are fused clusters of vascular channels that are closely apposed to the posterior surface of the lens, retinal dysplasia, and corneal thickening (Figure 1B,D). Lens epithelial cells encircled the lens, the characteristic bowing of lens fiber cells was lost (Figure 1D), and vascular invasion frequently led to intralenticular hemorrhage. Ultrastructural investigations (E15.5) revealed that both endothelial cells and pericytes contributed to a hyperplastic hyaloid vasculature on the posterior pole of the lens, with numerous attendant macrophages (Figure 1E-H).
###end p 36
###begin p 37
###xml 51 54 51 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 192 193 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 194 195 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 291 292 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 597 598 597 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 610 613 610 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 626 627 626 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 746 749 746 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 767 768 767 768 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 905 906 905 906 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 919 922 919 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 940 941 940 941 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1010 1011 1010 1011 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</bold>
###xml 1039 1042 1039 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 355 370 <span type="species:ncbi:10090">transgenic mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 923 938 <span type="species:ncbi:10090">transgenic mice</span>
Gross anatomical and microscopic features of VEGF-A188 transgenic mice. Representative photomicrographs of toluidine blue-stained sections from E18.5 wild-type (A,C) and VEGF-A188 transgenic (B,D) mice. Gross ocular phenotypes of adult wild-type (A; inset) and a VEGF-A188 transgenic mouse (B; inset), showing conspicuous cataract formation. In VEGF-A188 transgenic mice (B, D), a hypertrophic hyaloid vasculature surrounds a small lens. There is evidence of retinal hypertrophy, particularly in the ganglion cell layer at the top of these micrographs. Scanning electron micrographs of wild-type (E) and VEGF-A188 transgenic (F) mice are shown. The thickened hypertrophic hyaloid vasculature with numerous adherent mononuclear cells in the VEGF-A188 transgenic lens (F) contrasts with the organized plexus in wild-type mice. Transmission electron micrographs of hyaloid blood vessels in E18.5, wild-type (G), and VEGF-A188 transgenic mice (H). Large diameter vessels(LDBV), with several attendant macrophages (M), are conspicuous in VEGF-A188 transgenics. In the images, C=cornea, HV=hyaloid vasculature, R=retina, and L=lens.
###end p 37
###begin title 38
Ocular volume and tissue fraction stereology
###end title 38
###begin p 39
###xml 33 36 33 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 145 146 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 177 178 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 189 198 183 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 514 516 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 650 657 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 715 718 709 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 719 734 <span type="species:ncbi:10090">transgenic mice</span>
Absolute ocular volumes in VEGF-A188 transgenic mice were an average of 33% smaller than their control littermates (mean+/-SEM=1.1791+/-0.0287 mm3, transgenic=0.7849+/-0.1180 mm3; p<0.008; Figure 2A). In late fetal mice, there are two distinct anatomical regions of the hyaloid vasculature: that surrounding the lens (tunica vascular lentis, TVL, which incorporates the papillary membrane anteriorly), and a retinal component (arteria hyaloidea propria, AHP) on the vitreal surface of the inner limiting membrane [22]. Lenticular vessel proportions (TVL) were increased four fold and retinal vessels (AHP) two fold when compared with wild-type eyes (Table 1), with lens hemorrhage only ever being observed in VEGF-A188 transgenic mice (6/6 transgenics; 0/5 controls).
###end p 39
###begin p 40
###xml 62 65 62 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
###xml 688 703 <span type="species:ncbi:10090">transgenic mice</span>
Ocular and hyaloid vascular dimensions in wild-type and VEGF-A188 transgenic mice. Total ocular volume (A), hyaloid blood vessel length (B), cross-sectional area (C), and total blood vessel volume (D; blood vessel volume=length times cross-sectional area) in E18.5 fetuses from wild-type (n=6) and transgenic (n=5) littermates. Systematic random sampling and stereological methods were used to determine the dimensions of each parameter (see Methods). Statistical analysis was performed using one-way ANOVA with post-hoc testing (SPSS v11.0). The asterisk indicates a p<0.008, the double asterisk indicates a p<0.002, and the sharp (hash mark) indicates a p<0.0001 (wild-type compared to transgenic mice at E18.5). The error bars represent the mean+/-SEM.
###end p 40
###begin title 41
###xml 70 73 70 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
Proportions and tissue volumes of tissue types in wild-type and VEGF-A188 transgenic mice.
###end title 41
###begin p 42
###xml 69 72 69 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Proportion of total ocular tissue types in wild-type (n=5) and VEGF-A188 transgenic (n=6) mice. Values represent mean+/-SEM. Statistical comparisons between groups were performed using one-way ANOVA, with significant differences designated by an asterisk. Significance was accepted as p<0.05.
###end p 42
###begin p 43
###xml 149 152 149 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 411 414 411 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 623 630 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 730 733 730 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 892 899 892 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 951 959 951 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 1031 1034 1031 1034 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1177 1184 1177 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1294 1297 1294 1297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 153 168 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1035 1050 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
The total proportion of lens tissue (stroma plus hemorrhagic tissue) decreased by 39%, whereas lens stromal tissue alone was reduced by 62% in VEGF-A188 transgenic mice in comparison to littermate controls. In addition to these conspicuous changes in lens morphology, the fraction of retina, iris, and optic stalk tissue were all significantly increased (Table 1). The fractional proportion of vessels in VEGF-A188 transgenic eyes increased in comparison to controls in the AHP (p=0.003), iris (p=0.02), and optic stalk (p=0.01); however, the absolute ocular volumes of these tissue types were not significantly different (Table 1). This indicates that these tissue types were relatively unaffected by the overexpression of VEGF-A188, but they occupied a greater volume in a smaller eye. Additionally, despite having a smaller retinal volume, the proportion of AHP and TVL vessels increases (Table 1), particularly in regions around the lens equator (Figure 1). Perilenticular retinal hypertrophy was a consistent feature of VEGF-A188 transgenic mice, and general retinal thickening was a consistent finding (both features observed in five out of six transgenic eyes at E18.5; Table 1). To determine whether this vascular and retinal hypertrophy is associated with conspicuous HSPG-bound VEGF-A188 in the lens capsule and adjacent retinal surface, we performed immunohistochemical analysis on critically oriented specimens from E18.5 mice.
###end p 43
###begin title 44
Ocular blood vessel stereology
###end title 44
###begin p 45
###xml 68 77 68 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 152 161 152 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 178 181 178 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 258 267 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2D</xref>
###xml 369 372 369 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 468 483 468 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B,D,F,H</xref>
###xml 182 197 <span type="species:ncbi:10090">transgenic mice</span>
###xml 373 388 <span type="species:ncbi:10090">transgenic mice</span>
Although blood vessel length was not significantly altered (p<0.58; Figure 2B), the hyaloid vascular cross-sectional area increased two fold (p<0.0001; Figure 2C) in E18.5 VEGF-A188 transgenic mice, resulting in a doubling of total vascular volume (p<0.002; Figure 2D). This increase in cross-sectional area of hyaloid vasculature surrounding the lenses of E18.5 VEGF-A188 transgenic mice is particularly conspicuous on the posterior and lateral surfaces of the lens (Figure 1B,D,F,H).
###end p 45
###begin title 46
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Measurement of corneal thickness in neonatal mice
###end title 46
###begin p 47
###xml 158 161 158 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 268 271 268 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 491 494 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 272 287 <span type="species:ncbi:10090">transgenic mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
The non-parametric Friedman test showed that there were no significant differences between wild-type embryos selected from different litters containing VEGF-A188 mice (p<0.704; n=45). The number of layers comprising the cornea was significantly increased in the VEGF-A188 transgenic mice (15.7+/-0.99, mean+/-SEM endothelial cells thick, n=10) in comparison with wild-type mice (12.93+/-0.50 layers thick, mean+/-SEM, p<0.033). Despite an increase in the number of corneal layers, the VEGF-A188 transgenic eyes did not have an increased corneal thickness in comparison with wild-type mice (p>0.05).
###end p 47
###begin title 48
VEGF immunohistochemistry
###end title 48
###begin p 49
###xml 117 125 117 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 237 250 237 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B,D,F</xref>
###xml 417 420 417 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 438 451 438 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C,E,G</xref>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Specific immunohistochemical staining for VEGF-A was observed in sections from the eyes of E15.5, P1 and adult mice (Figure 3). Weak cytoplasmic staining of the retina, lens stroma, and outer lens capsule was observed in wild-type eyes (Figure 3B,D,F). Strong VEGF-A specific immunostaining was observed in the lens, retina, lens capsule, and surrounding the aberrant hyaloid vasculature of E15.5, P1 and adult VEGF-A188 transgenic eyes (Figure 3C,E,G, respectively).
###end p 49
###begin p 50
###xml 206 207 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 208 209 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 216 217 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 218 219 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 233 234 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 235 236 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 239 240 235 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 324 325 320 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 549 550 545 546 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 581 582 577 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 810 811 806 807 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 824 825 820 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 878 879 874 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1066 1067 1062 1063 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1068 1069 1064 1065 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 1083 1084 1075 1076 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</bold>
###xml 1085 1086 1077 1078 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</bold>
###xml 1100 1101 1092 1093 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</bold>
###xml 1102 1103 1094 1095 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q</bold>
###xml 1129 1130 1121 1122 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1131 1132 1123 1124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 1134 1135 1126 1127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</bold>
###xml 1136 1137 1128 1129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q</bold>
###xml 1150 1151 1142 1143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 1152 1153 1144 1145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 1171 1172 1163 1164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1341 1342 1333 1334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1451 1452 1443 1444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 1539 1540 1531 1532 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 1661 1662 1653 1654 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 1929 1930 1921 1922 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</bold>
###xml 1953 1954 1945 1946 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</bold>
###xml 2025 2026 2017 2018 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</bold>
###xml 2055 2056 2047 2048 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q</bold>
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 1155 1159 <span type="species:ncbi:10090">mice</span>
###xml 1284 1289 <span type="species:ncbi:10090">mouse</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1467 1482 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1608 1612 <span type="species:ncbi:10090">mice</span>
###xml 1683 1698 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2043 2048 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical detection of VEGF, HSPG, alpha-SMA, and F4/80 in eyes from wild-type and VEGF-A transgenic mice. Immunohistochemical detection of VEGF-A in wild-type and transgenic mouse eyes at E15.5 (A-C), P1 (D+E), and adult (F-G). A; Non-specific IgG serum (control), no discernible background staining is observed. B: VEGF-A immunostaining is observed in the wild-type lens (L) and superficial layers of the retina (black arrow) at E15.5. However specific VEGF-A staining was not detected at P1 in the retina, lens, or hyaloid vasculature (D). In the adult wild-type eye (F), specific staining of the surface of the lens capsule is seen (arrows). Specific staining for VEGF-A is observed in the lens (L), retina (black arrows) and adjacent to the hyaloid vasculature (black arrowheads) at both E15.5 (C) and at P1 (E) in VEGF-A188 transgenics. In adult VEGF-A188 mice (G), prominent staining is observed in the lens capsule (arrows) which appears thinner and (during processing) has separated from the lens structure. Immunohistochemical detection of HSPG (H-L), alpha-SMA (M-O), and F4/80 (P,Q) in sections from E15.5 (H-J, M-Q) and adult (K,L) mice are shown. H: No discernible background staining is observed in control sections (IgG-specific serum). Inset shows an E15.5 mouse brain section, which served as a positive control. I: In wild-type mice, specific HSPG staining is observed in the lens capsule and hyaloid vasculature (arrow). J: In VEGF-A188 transgenic mice, HSPG staining is observed in the lens capsule (arrow). K: HSPG staining is also observed in lens capsule of adult wild-type mice (arrow), with a characteristic laminar pattern. L: In adult VEGF-A188 transgenic mice, HSPG staining is seen in the thin lens capsule (arrow) and around persistent hyaloid vasculature (open arrows). Conspicuous staining of peri-vascular smooth muscle cells surrounding blood vessels (arrow) in both E15.5 wild-type (N) and transgenic eyes (O) was noted. F4/80 immunoreactivity in sections from E15.5 wild- type (P) and transgenic mouse eyes (Q) revealed cells adjacent to the hyaloid vasculature. In the images, L=lens, R=retina, HV=hyaloid vasculature.
###end p 50
###begin title 51
HSPG imunohistochemistry
###end title 51
###begin p 52
###xml 129 140 129 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3H,I</xref>
###xml 152 155 152 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 157 166 157 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3J</xref>
###xml 236 247 236 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3I,K</xref>
###xml 350 353 350 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 360 371 360 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3J,L</xref>
###xml 526 537 526 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3J,L</xref>
###xml 168 183 <span type="species:ncbi:10090">transgenic mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 509 524 <span type="species:ncbi:10090">transgenic mice</span>
Immunohistochemical staining for HSPG revealed antibody-specific staining in the lens capsules from the eyes of E15.5 wild-type (Figure 3H,I) and VEGF-A188 (Figure 3J) transgenic mice. Lens capsules from E15.5 and adult wild-type mice (Figure 3I,K) were considerably thicker and showed a laminar pattern of HSPG immunostaining in comparison to VEGF-A188 mice (Figure 3J,L), where lens capsules were attenuated and intensely HSPG immunoreactive. Staining was also conspicuous around the hyaloid vasculature of transgenic mice (Figure 3J,L).
###end p 52
###begin title 53
alpha-smooth muscle actin immunohistochemistry
###end title 53
###begin p 54
###xml 177 188 169 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3M,N</xref>
###xml 206 215 198 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3O</xref>
###xml 368 376 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
Specific staining for alpha-smooth muscle actin (alpha-SMA) was observed in periendothelial cells located on the ablumenal vascular surfaces of capillaries from both wild-type (Figure 3M,N) and transgenic (Figure 3O) mice. In addition, the numbers of pericytes per vessel, as identified by ultrastructural features, was greater in transgenic than littermate controls (Figure 4).
###end p 54
###begin p 55
###xml 100 103 100 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 195 198 195 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 311 314 311 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 449 452 449 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 104 119 <span type="species:ncbi:10090">transgenic mice</span>
###xml 453 468 <span type="species:ncbi:10090">transgenic mice</span>
Numbers of ultrastructurally identified cells within the hyaloid vasculature of wild-type and VEGF-A188 transgenic mice. Ultrastructural quantitation of cells in the hyaloid vasculature of VEGF-A188 transgenics and control littermates. Quantitation of median coronal sections from E13.5, E15.5, and E17.5 VEGF-A188 transgenics and control littermates revealed a consistent 3:1 endothelial cell:pericyte ratio. N=4 per group. WT=wild-type. 188=VEGF-A188 transgenic mice.
###end p 55
###begin title 56
F4/80 immunohistochemistry
###end title 56
###begin p 57
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 187 190 187 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 208 219 208 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3P,Q</xref>
###xml 191 206 <span type="species:ncbi:10090">transgenic mice</span>
Cells immunostained with the F4/80 antibody, which detects cells from the monocyte/macrophage lineage [23], were observed adhering to the hyaloid vasculatures in both wild-type and VEGF-A188 transgenic mice (Figure 3P,Q, respectively).
###end p 57
###begin title 58
Cell types comprising the hyaloid vasculature
###end title 58
###begin p 59
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 274 277 274 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 456 464 456 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 368 383 <span type="species:ncbi:10090">transgenic mice</span>
###xml 917 932 <span type="species:ncbi:10090">transgenic mice</span>
The hyaloid vasculature is comprised of three primary cell types: endothelium, specialized macrophages (hyalocytes), and pericytes [24]. Ultrastructural features were used to identify these cell types in representative median sagittal sections from both wild-type and VEGF-A188 transgenic eyes. There is an increase in the number of endothelial cells and pericytes in transgenic mice compared with littermate controls at E13.5, E15.5, and E17.5 (P<0.0001, Figure 4). Although there is a 2/3 fold increase in both ECs and pericytes, the ratios of these cell types remained relatively constant throughout fetal development. At E13.5 the ratio of EC:pericytes was 3.88:1 (wild-type) and 4.02:1 (transgenic), compared to E15.5 at 5.08:1 (wild-type) and 3.33:1 (transgenic) and E17.5, where the ratio was 3.89:1 (wild-type) and 3.19:1 (transgenic). Although the trend was toward greater numbers of F4/80 positive cells in transgenic mice, we observed no statistical difference compared to littermate controls (p=0.051).
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 423 426 423 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 655 658 655 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 753 756 753 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 829 830 825 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 952 955 948 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 957 958 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 969 972 965 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1093 1096 1089 1092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 1130 1131 1126 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1243 1244 1239 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1299 1302 1295 1298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 1424 1427 1420 1423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 18 24 <span type="species:ncbi:9606">humans</span>
###xml 256 263 <span type="species:ncbi:9606">infants</span>
###xml 427 442 <span type="species:ncbi:10090">transgenic mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
Microphthalmia in humans is associated with a range of inherited genetic abnormalities, including microphthalmia with linear skin defects (MLS) syndrome [25], Lenz microphthalmia [26,27], and Norrie's disease [28]. Microphthalmia is frequently observed in infants affected with PHPV [29] and this disorder is also commonly associated with premature birth. In the present study, the characteristic ocular phenotype of VEGF-A188 transgenic mice is microphthalmia, cataracts, persistent hyperplastic hyaloid vasculature, lens defects, and retinal hyperplasia. The microphthalmia and cataract formation is also a characteristic specifically observed in VEGF-A188 mice. This phenotype was not previously reported in mice overexpressing the more labile VEGF-A165 isoform when it was overexpressed from the alphaA-crystalline promoter [1]. In addition, the HV and lens abnormalities are morphologically distinct when either of these two isoforms (i.e., VEGF-A165 [1] or VEGF-A188 [this study]) is overexpressed - for example, the reduction in lens size is in contrast to observations made when VEGF-A165 was overexpressed from the lens [1], where the lens had expanded to fill the space within the vitreal and aqueous compartments. Ash and Overbeek [1] suggest that the enlarged lens observed in the VEGF-A165 mice may be due to fluid accumulation in the center of the lens. It is possible that reduction in lens size in the VEGF-A188 mice resulted from a lack of nutrients and oxygen obtained from the abnormal TVL and that the disrupted lens fiber cell formation also added to the delayed development of the lens.
###end p 61
###begin p 62
###xml 79 82 79 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 83 98 <span type="species:ncbi:10090">transgenic mice</span>
###xml 141 145 <span type="species:ncbi:10116">rats</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 472 479 <span type="species:ncbi:9606">patient</span>
A significant reduction in lens size, coupled with cataract formation in VEGF-A188 transgenic mice, is similar to the phenotype described in rats that are administered with monosodium-L-glutamate on the 9th and 10th day after birth [30]. Small, cataractous lenses are also associated with the "small eyes" (Sey) phenotype, a semidominant, homozygous-lethal mutation in the mouse [31]. The lenticular hemorrhaging observed in the present study parallels that observed in a patient with congenital cataracts. In the aforementioned study, the authors concluded that the cause of the blood clot was a rupture of the anterior end of the hyaloid artery [32] (attached to the posterior lens surface) and that leakage from hyaloid vessels invading the lens nucleus may be responsible for intralenticular bleeding in such eyes [33].
###end p 62
###begin p 63
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 306 309 306 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 527 530 527 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 577 580 577 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 790 793 790 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 840 843 840 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1016 1019 1016 1019 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 1172 1173 1172 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1301 1304 1301 1304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1497 1499 1497 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1599 1601 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 1837 1839 1837 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 2030 2031 2030 2031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 2153 2156 2153 2156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 2304 2307 2304 2307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 2390 2393 2390 2393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">165</sub>
###xml 2400 2401 2400 2401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 2542 2544 2542 2544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 2582 2585 2582 2585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 2893 2896 2893 2896 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 294 299 <span type="species:ncbi:9606">human</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 714 728 <span type="species:ncbi:93934">Japanese quail</span>
###xml 844 859 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1305 1320 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2172 2176 <span type="species:ncbi:10090">mice</span>
###xml 2308 2323 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2394 2398 <span type="species:ncbi:10090">mice</span>
###xml 2897 2901 <span type="species:ncbi:10090">mice</span>
It is known that VEGF-A is vital to fetal ocular neovascularization [34], particularly during the formation of the HV and retinal vasculatures [1,8,35]. VEGF levels are also often elevated in ocular disorders, where increased vascularization is observed [15,17]. In addition, overexpression of human VEGF-A165 under the control of the rhodopsin promoter results in a degenerative phenotype characterized by increased retinal vascularization [18]. The doubling of the hyaloid vascular volumes and cross-sectional areas in VEGF-A188 mice is consistent with studies in both VEGF-A165 overexpressing tumors [36], where vessel fusion resulted in abnormally large lumen formation and also in normally avascular areas in Japanese quail embryos following injection of nanomolar quantities of VEGF-A165 at the onset of vasculogenesis [37]. In VEGF-A188 transgenic mice (this study), EC number was significantly increased over that in controls from E13.5-E18.5, and these results are consistent with those described for VEGF-A165 mice, where proliferation of presumed endothelial precursor cells juxtaposed to the lens was high during the late fetal period and declined thereafter [1]. The concomitant two to three fold increase of both EC and pericyte numbers during late fetal ocular vascularization of VEGF-A188 transgenic mice (this study) is consistent with the hypothesis that the proliferation and cell localization of these cell types are intimately linked. VEGF-A is a known mitogen for pericytes [38], and as both ECs and pericytes express VEGF-R2 they are able to respond to this growth factor [39,40]. Previous studies have also shown that VEGF-A promotes maturation of pericytes within the developing retina [41], and that melanoma cells transfected with VEGF-A cDNA promote a strong proliferative response in both pericytes and ECs [42]. Poor blood vessel development has been suggested to be the result of an insufficient population of mesenchymal cells and pericytes to interact with the overabundance of endothelial cells [1]. This study provides an alternative hypothesis, namely that the pericyte population observed, in both control and VEGF-A188 overexpressing mice, increases in tandem with EC number. Hyalocyte (F4/80) positive cells are observed as early as E13.5 in both control and VEGF-A188 transgenic mice, in contrast to the low numbers of these cells described in VEGF-A165 mice [1]. Hyalocytes are now well known to play a key role in the regression of the hyaloid vasculature, particularly via the expression of Wnt-7b [43]. Our results suggest that the VEGF-A188 isoform promotes an increase in hyalocyte numbers, albeit not a statistically significant difference, both within the hyaloid vessel walls and on the ablumenal surface. The role of hyalocytes in the ocular pathology remains to be determined, but the results suggest that as the HV volume increases in VEGF-A188 mice, the numbers of hyalocytes do not proportionally increase.
###end p 63
###begin p 64
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 669 672 669 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 764 767 764 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 996 999 996 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 1686 1688 1686 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r54">54</xref>
###xml 1855 1858 1855 1858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 36 51 <span type="species:ncbi:10090">transgenic mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 872 887 <span type="species:ncbi:10090">transgenic mice</span>
Stereological analysis of VEGF-A188 transgenic mice revealed a significantly increased proportion of retina in comparison to wild-type mice, coupled with conspicuous immunolabeling for VEGF in the hypertrophic retina, particularly adjacent to the lens equator. Reduced VEGF-A production in the eye is a cause of retinal thinning [44] and conversely, retinal thickening has been observed in mice with retinal ischemia (associated with increased VEGF-A levels) caused by a surgically increased intraocular pressure [45]. Our data cannot definitively differentiate between retinal hypertrophy resulting from inappropriate neovascularization or as a direct effect of VEGF-A188 overexpression on ganglion cell proliferation and differentiation. Overexpression of VEGF-A188 from the developing lens also resulted in an increased number of layers in the postnatal cornea of VEGF transgenic mice. One possible explanation for this increased number of EC layers in VEGF-A transgenic corneas is that VEGF-A188 transgenic eyes may be subjected to an increased intraocular pressure in relation to the wild-type eye. Several studies have shown that increased intraocular pressure can result in a thickening of the cornea [46-53], however thickening was not observed in our study despite the increase in corneal ECs. Although corneal thickening had not occurred, the properties of the cornea such as protection against noxious agents, biomechanical stability, and structural resiliency as well as the ability to filter out damaging UV light and to aid light refraction may be altered by an increase in density of the cornea. VEGF was originally discovered and termed as vascular permeability factor [54]; therefore, with an increased number of hyaloid blood vessels which are more permeable (as evidenced from the histological and ultrastructural examinations of VEGF-A188 transgenic eyes), leakage of serum proteins is highly likely contribute to the ocular pathology we describe.
###end p 64
###begin p 65
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r55">55</xref>
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r56">56</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 758 761 758 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 913 916 913 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r57">57</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r58">58</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r60">60</xref>
###xml 20 26 <span type="species:ncbi:9606">humans</span>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 672 687 <span type="species:ncbi:10090">transgenic mice</span>
###xml 995 999 <span type="species:ncbi:10090">mice</span>
###xml 1004 1010 <span type="species:ncbi:9606">humans</span>
Previous studies in humans [55] and in mice [1] have demonstrated that VEGF-A is expressed within the lens and supports early fetal lens growth by stimulating the proliferation and migration of angioblasts. In addition to the developmental significance of VEGF-A, a range of ocular pathologies are characterized by inappropriate neovascularization and are coincident with increased levels of VEGF-A. These include proliferative diabetic retinopathy [15,17], age-related macular degeneration [56], retinal neovascularization [18], and retinopathy of prematurity [16]. The immunohistochemical data from this study confirm that VEGF-A is overexpressed within the lens of the transgenic mice and deposited within the lens capsule, where HSPG co-localizes. VEGF-A188 has a strong affinity for heparin [12] and the specific lens capsule accumulation of this protein along with HSPG, is consistent with a role for VEGF-A188 (and other VEGF-A heparin binding isoforms) in response to wounding. In adult mice and humans, the lens capsule is normally avascular [57], however, following injury such as lens replacement, intense neovascularization surrounding the lens capsule is a common indication for further surgical intervention [58-60]. The presence of HSPG-bound high molecular weight VEGF-A isoforms in the lens may thus prove to be amenable to therapeutic intervention, reducing the incidence of pathological neovascularization.
###end p 65
###begin p 66
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 324 327 324 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r61">61</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r62">62</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r63">63</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r64">64</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r65">65</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r63">63</xref>
###xml 784 787 784 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 881 884 881 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">188</sub>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 554 558 <span type="species:ncbi:9685">cats</span>
###xml 565 569 <span type="species:ncbi:9615">dogs</span>
###xml 620 626 <span type="species:ncbi:9844">llamas</span>
###xml 657 672 <span type="species:ncbi:10116">laboratory rats</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
During normal development of the human eye, the hyaloid vasculature nurtures the developing lens during intrauterine life; in PHPV however, the hyaloid tissue fails to regress and forms a fibrovascular mass behind the lens, resulting in cataracts [29] and bleeding into the vitreous - phenotypes characteristic of the VEGF-A188 model. PHPV is a common congenital developmental anomaly of the eye [61], affecting around one in 15,000 live births [62]. Various mammalian species show morphologic features of PHPV, as the disorder has also been reported in cats [63], dogs (where the condition is commonly bilateral [64]), llamas (also bilateral [65]), and in laboratory rats [63], however the etiology of the disorder has not been established. In addition to revealing a role for VEGF-A188 in large vessel formation, microphthalmia, lens anomalies and retinal hypertrophy, the VEGF-A188 mice described in this study are phenotypically similar to PHPV and should serve as a useful model for preclinical testing of potential therapeutic treatments of this condition.
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
The authors extend their gratitude to Professor Terry Mayhew (University of Nottingham) for advice on stereology and statistical analysis. The authors would like to acknowledge the expert animal care of Mrs. M. Mitchell and Mr. T. Gray and Mr P. Hinson (Electron Microscopy Unit, Division of Pathology, Queen's Medical Centre, Nottingham, UK) for assistance with specimen preparation. We would also like to thank Dr. C. Walsh for critical reading of the manuscript.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling.
###end article-title 70
###begin article-title 71
Lens-specific expression of PDGF-A alters lens growth and development.
###end article-title 71
###begin article-title 72
Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury.
###end article-title 72
###begin article-title 73
Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.
###end article-title 73
###begin article-title 74
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
###end article-title 74
###begin article-title 75
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
###end article-title 75
###begin article-title 76
###xml 53 57 <span type="species:ncbi:10090">mice</span>
VEGF is required for growth and survival in neonatal mice.
###end article-title 76
###begin article-title 77
Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium.
###end article-title 77
###begin article-title 78
Molecular and biological properties of the vascular endothelial growth factor family of proteins.
###end article-title 78
###begin article-title 79
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences.
###end article-title 79
###begin article-title 80
Vascular endothelial growth factor is a secreted angiogenic mitogen.
###end article-title 80
###begin article-title 81
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
###end article-title 81
###begin article-title 82
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Differential expression of VEGF isoforms in mouse during development and in the adult.
###end article-title 82
###begin article-title 83
In vitro assessment of the biological activity of basic fibroblast growth factor released from various polymers and biomatrices.
###end article-title 83
###begin article-title 84
###xml 125 131 <span type="species:ncbi:10090">murine</span>
Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy.
###end article-title 84
###begin article-title 85
Specificity of subnormal deltaPO2 for retinal neovascularization in experimental retinopathy of prematurity.
###end article-title 85
###begin article-title 86
Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
###end article-title 86
###begin article-title 87
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.
###end article-title 87
###begin article-title 88
Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens.
###end article-title 88
###begin article-title 89
The efficiency of systematic sampling in stereology and its prediction.
###end article-title 89
###begin article-title 90
Methodological problems in placental morphometry: apologia for the use of stereology based on sound sampling practice.
###end article-title 90
###begin article-title 91
Development and pathology of the hyaloid, choroidal and retinal vasculature.
###end article-title 91
###begin article-title 92
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Markers of mouse macrophage development detected by monoclonal antibodies.
###end article-title 92
###begin article-title 93
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human hyaloid system: cellular phenotypes and inter-relationships.
###end article-title 93
###begin article-title 94
Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization of 11 cases.
###end article-title 94
###begin article-title 95
Genetic heterogeneity of syndromic X-linked recessive microphthalmia-anophthalmia: is Lenz microphthalmia a single disorder?
###end article-title 95
###begin article-title 96
Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR.
###end article-title 96
###begin article-title 97
Molecular dissection of Norrie disease.
###end article-title 97
###begin article-title 98
Locus for autosomal recessive nonsyndromic persistent hyperplastic primary vitreous.
###end article-title 98
###begin article-title 99
###xml 71 75 <span type="species:ncbi:10116">rats</span>
Morphological studies on cataract and small lens formation in neonatal rats treated with monosodium-L-glutamate.
###end article-title 99
###begin article-title 100
###xml 48 52 <span type="species:ncbi:9615">dogs</span>
Color dilution and hereditary defects in collie dogs.
###end article-title 100
###begin article-title 101
Haemorrhage in the lens: spontaneous occurrence in congenital cataract.
###end article-title 101
###begin article-title 102
The surgical and nonsurgical management of persistent hyperplastic primary vitreous.
###end article-title 102
###begin article-title 103
Ocular neovascularization: clarifying complex interactions.
###end article-title 103
###begin article-title 104
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.
###end article-title 104
###begin article-title 105
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.
###end article-title 105
###begin article-title 106
Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.
###end article-title 106
###begin article-title 107
VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis.
###end article-title 107
###begin article-title 108
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
###end article-title 108
###begin article-title 109
In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A.
###end article-title 109
###begin article-title 110
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis.
###end article-title 110
###begin article-title 111
Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.
###end article-title 111
###begin article-title 112
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature.
###end article-title 112
###begin article-title 113
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling.
###end article-title 113
###begin article-title 114
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice.
###end article-title 114
###begin article-title 115
###xml 109 116 <span type="species:ncbi:9986">rabbits</span>
Intraocular pressure and corneal curvature changes on application of limbal-scleral suction fixation ring in rabbits.
###end article-title 115
###begin article-title 116
Corneal endothelial cells in essential iris atrophy. A specular microscipic study.
###end article-title 116
###begin article-title 117
Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes.
###end article-title 117
###begin article-title 118
Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma.
###end article-title 118
###begin article-title 119
Corneal thickness in glaucoma: an important parameter?
###end article-title 119
###begin article-title 120
Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).
###end article-title 120
###begin article-title 121
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Increased corneal thickness in patients with ocular hypertension.
###end article-title 121
###begin article-title 122
Central corneal thickness, tonometry, and ocular dimensions in glaucoma and ocular hypertension.
###end article-title 122
###begin article-title 123
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
###end article-title 123
###begin article-title 124
###xml 36 41 <span type="species:ncbi:9606">human</span>
VEGF and KDR gene expression during human embryonic and fetal eye development.
###end article-title 124
###begin article-title 125
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
###end article-title 125
###begin article-title 126
Lens morphology, aging, and cataract.
###end article-title 126
###begin article-title 127
Posttraumatic neovascularization in a cataractous crystalline lens.
###end article-title 127
###begin article-title 128
Posttraumatic neovascularization in a cataractous crystalline lens.
###end article-title 128
###begin article-title 129
Cataract wound neovascularization. An often overlooked cause of vitreous hemorrhage.
###end article-title 129
###begin article-title 130
Persistent hyperplastic primary vitreous.
###end article-title 130
###begin article-title 131
###xml 90 94 <span type="species:ncbi:10090">mice</span>
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice.
###end article-title 131
###begin article-title 132
###xml 113 117 <span type="species:ncbi:9685">cats</span>
Persistent hyperplastic tunica vasculosa lentis and persistent hyperplastic primary vitreous (PHTVL/PHPV) in two cats.
###end article-title 132
###begin article-title 133
###xml 74 78 <span type="species:ncbi:9615">dogs</span>
Ocular complications of persistent hyperplastic primary vitreous in three dogs.
###end article-title 133
###begin article-title 134
###xml 61 66 <span type="species:ncbi:9844">llama</span>
###xml 68 78 <span type="species:ncbi:9844">Lama glama</span>
Congenital cataracts and persistent hyaloid vasculature in a llama (Lama glama).
###end article-title 134

